/ Futurism/ The ByteAdvanced TransportArtificial IntelligenceEarth & EnergyEnhanced HumansFuture SocietyHard ScienceHealth & MedicineOff WorldRobots & MachinesSci-Fi VisionsVirtuality
+Videos+Newsletter+Social
About UsContact UsAdvertise With Us
/ NeoscopeBreakthroughsCancerDevelopmentsDevicesGeneticsMental HealthNeuroscienceOrganic ChemistryRX/MedicinesRobotics/ProstheticsStudiesTreatments
Futurism Logo

Rx/Medicines

Topic

Latest Stories

Hold Up
9.9.20, 11:09 AM EDT on neoscope
COVID Vaccine Trial Paused After Volunteer Develops Mysterious Illness
Early Results
9.4.20, 2:59 PM EDT on neoscope
Finally, There's Evidence That the Russian COVID Vaccine Might Work
Trip Sitter
8.27.20, 4:14 PM EDT on neoscope
Research: LSD Microdoses as Effective as Opioids at Treating Pain
Guinea Pigs
8.21.20, 2:46 PM EDT on neoscope
40,000 Russians Are About to Get That Untested COVID-19 Vaccine
Mr. Ed Pitches In
8.17.20, 4:10 PM EDT on neoscope
A Low-Cost, Experimental Coronavirus Treatment Uses Horse Antibodies
Puff, Puff, Pass
Updated 8.12.20, 12:00 PM EDT on neoscope
Scientists Built an Inhaler They Claim Stops Coronavirus
Local Drugstore
Updated 8.8.20, 2:18 PM EDT on neoscope
Meet the Woman Who Wants to Sell Psychedelic Drugs to Scientists
Rushing Ahead
8.4.20, 4:38 PM EDT on neoscope
Russian Officials Are Injecting Themselves With an Experimental COVID Vaccine
Molecular FedEx
7.28.20, 12:41 PM EDT on neoscope
Gene Therapy Lets Boy With Muscular Dystrophy Walk Again
Final Round
7.27.20, 11:20 AM EDT on neoscope
An Experimental COVID-19 Vaccine Begins its Phase 3 Trial Today
Hidden Risks
7.22.20, 3:57 PM EDT on neoscope
Experimental COVID Vaccines Are Giving People Fevers, Headaches, and More
Take It With You
7.21.20, 5:11 PM EDT on neoscope
Pharma Execs Say They Plan to Profit on COVID-19 Vaccine
  • Previous
  • 1
  • ...
  • 15
  • 16
  • 17
  • ...
  • 19
  • Next
+Social+Newsletter
TopicsAbout UsEditorial StandardsContact Us

DISCLAIMER(S)

Privacy PolicyTerms & ConditionsDMCA Policy

Articles may contain affiliate links which enable us to share in the revenue of any purchases made.

Registration on or use of this site constitutes acceptance of our Terms of Service.

© Recurrent Ventures Inc, All Rights Reserved.